Profile
Michael Kalos is an Independent Director at IMV, Inc. and a Managing Director at Next Pillar Consulting, LLC.
He was formerly the Chief Scientific Officer at Eli Lilly & Co., the Vice President-Immunooncology at Janssen Pharmaceuticals, Inc., and the Executive VP & Head-Research & Development at Arsenal Biosciences, Inc. He holds a doctorate degree from the University of Minnesota.
Michael Kalos active positions
| Companies | Position | Start |
|---|---|---|
| IMV INC. | Director/Board Member | 2021-05-10 |
Next Pillar Consulting, LLC | Chief Executive Officer | - |
Former positions of Michael Kalos
| Companies | Position | End |
|---|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Chief Tech/Sci/R&D Officer | - |
Training of Michael Kalos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Develops cellular drug discovery tools to provide medicines for cancer treatment and operates cell manufacturing platform | Technology Services |
Next Pillar Consulting, LLC |
- Stock Market
- Insiders
- Michael Kalos
















